Publications by authors named "Jamieson Ayton"
Cell Death Dis
March 2024
Article Synopsis
- * Research indicates that the effectiveness of this combination is hindered by its inability to induce cell death (apoptosis), despite changes in related proteins, suggesting that MCL-1 and BCL-X are overexpressed in BRAF CRCs.
- * Combining encorafenib with BCL-X inhibitors has shown promise in enhancing apoptosis in cancer cells, with one experimental approach (DT2216) resulting in increased cell death in lab tests and successful tumor growth reduction
